Nanorobots vs cancer, the newest low-cost drug concept
Nano Magazine - 05-Feb-2020Made of DNA fragments, nanorobots will be used to locate and destroy cancer cells
Join the club for FREE to access the whole archive and other member benefits.
ITMO University researcher
Ekaterina is a results-driven Business Analyst and Product Owner with 3+ years of relevant experience including a background in Life Science and Healthcare domains.
She engages with science and optimize R&D processes, making them more efficient. She always stays connected with the latest trends in the field and has the ability to structure data in a way that brings practical impact.
Ekaterina started her career as a medical doctor, specializing in the treatment of oncological diseases in children and conducting scientific research on the topic of Graft-versus-Host disease. Later, she decided to expand her scientific knowledge by transitioning into academia. She was not only a researcher, but also a project manager, supervising the development and market launch of diagnostic kits and collaborating as a business stakeholder in configuring LIMS platforms. This multifaceted experience provided me with a deep understanding of processes from both sides and allowed her to dive deeper into business analysis.
See also: AstraZeneca - Pharmaceutical and biopharmaceutical company that develops innovative drugs
Details last updated 06-Feb-2020
Made of DNA fragments, nanorobots will be used to locate and destroy cancer cells